1. Home
  2. MDBH vs DYAI Comparison

MDBH vs DYAI Comparison

Compare MDBH & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$2.93

Market Cap

32.3M

Sector

N/A

ML Signal

HOLD

Logo Dyadic International Inc.

DYAI

Dyadic International Inc.

HOLD

Current Price

$0.51

Market Cap

32.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
DYAI
Founded
1997
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3M
32.5M
IPO Year
2022
2003

Fundamental Metrics

Financial Performance
Metric
MDBH
DYAI
Price
$2.93
$0.51
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
2.2K
170.0K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,090,345.00
Revenue This Year
N/A
$122.79
Revenue Next Year
N/A
$100.00
P/E Ratio
$4.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$0.48
52 Week High
$4.80
$1.60

Technical Indicators

Market Signals
Indicator
MDBH
DYAI
Relative Strength Index (RSI) 46.35 23.46
Support Level $2.81 N/A
Resistance Level $3.22 $0.88
Average True Range (ATR) 0.12 0.06
MACD -0.01 -0.02
Stochastic Oscillator 33.80 5.97

Price Performance

Historical Comparison
MDBH
DYAI

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The company operates in two reportable segments: a broker dealer & intellectual property service; and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About DYAI Dyadic International Inc.

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: